Europe Travel Vaccine Market - Industry Trends and Forecast to 2033

Description

List of Tables

Europe travel vaccine market is expected to reach USD 3,528,168.83 thousand by 2032 from USD 1,590,722.71 thousand in 2023, growing at a substantial CAGR of 9.4% in the forecast period of 2024 to 2032.

Market Segmentation:

Europe travel vaccines market, By Composition (Combination Vaccines and Mono Vaccines), Type (Inactivated Vaccines, Subunit, Recombinant, Polysaccharide and Conjugate Vaccines, Live-Attenuated Vaccines, Toxoid Vaccines, DNA Vaccines, and Viral Vector Vaccines), Category (Recommended Vaccine, Routine Vaccine and Required Vaccine), Disease (Typhoid, Hepatitis, Cholera, Varicella, Influenza, Japanese Encephalitis, Meningococcal Meningitis, Yellow Fever, Rabies, DPT, Measles and Mumps, Tick-Borne Encephalitis, Malaria, Covid-19, Polio and Others), Route of Administration (Injectable and Oral), Gender (Male and Female), Patient Type (Adult, Pediatric and Geriatric), Age Group (20-50 Years, Less than 20 Years and Above 50 Years), Distribution Channel (B2B and B2C), Countries (Germany, U.K., France, Italy, Netherlands, Spain, Russia, Switzerland, Poland, Norway, Hungary, Austria, Ireland, Lithuania, and Rest of Europe) - Industry Trends and Forecast to 2032

Some of the major factors contributing to the growth of the Europe travel vaccines market are:

Driver
Rising incidence of infectious diseases
Restraint
High cost of travel vaccines
Opportunity
Advancements in vaccine technology

Market Players

Some major companies dealing in the Europe travel vaccines market are:

GSK plc.
Bavarian Nordic
Pfizer Inc.
Abbott
CSL
AstraZeneca
Sanofi
Merck & Co., Inc.
Valneva SE
Johnson & Johnson Services Inc.
Dynavax Technologies.

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE TRAVEL VACCINES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.10 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
4.3 PIPELINE ANALYSIS

5 MARKET OVERVIEW

5.1 DRIVERS
- 5.1.1 RISING INCIDENCE OF INFECTIOUS DISEASES
- 5.1.2 INCREASING TRAVEL AND TOURISM
- 5.1.3 GOVERNMENT REGULATIONS AND RECOMMENDATIONS REGARDING VACCINATION
- 5.1.4 EXPANSION OF TRAVEL MEDICINE CLINICS
5.2 RESTRAINTS
- 5.2.1 HIGH COST OF TRAVEL VACCINES
- 5.2.2 REGULATORY HURDLES FOR APPROVAL
5.3 OPPORTUNITIES
- 5.3.1 ADVANCEMENTS IN VACCINE TECHNOLOGY
- 5.3.2 GROWING AWARENESS REGARDING VACCINES
- 5.3.3 INTEGRATION OF DIGITAL HEALTH SOLUTIONS
5.4 CHALLENGES
- 5.4.1 COLD CHAIN REQUIREMENTS FOR STORAGE
- 5.4.2 VACCINE HESITANCY AND MISINFORMATION

6 EUROPE TRAVEL VACCINE MARKET, BY COMPOSITION

6.1 OVERVIEW
6.2 COMBINATION VACCINES
6.3 MONO VACCINES

7 EUROPE TRAVEL VACCINE MARKET, BY TYPE

7.1 OVERVIEW
7.2 INACTIVATED VACCINES
- 7.2.1 HEPATITIS A
- 7.2.2 INFLUENZA
- 7.2.3 RABIES
- 7.2.4 TICK-BORNE ENCEPHALITIS
- 7.2.5 JAPANESE ENCEPHALITIS
- 7.2.6 POLIO
7.3 SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES
- 7.3.1 HEPATITIS B
- 7.3.2 MENINGOCOCCAL
- 7.3.3 MALARIA
- 7.3.4 COVID-19
7.4 LIVE-ATTENUATED VACCINES
- 7.4.1 TYPHOID
- 7.4.2 CHOLERA
- 7.4.3 YELLOW FEVER
- 7.4.4 MEASLES
- 7.4.5 MUMPS
- 7.4.6 RUBELLA
- 7.4.7 VARICELLA
- 7.4.8 OTHERS
7.5 TOXOID VACCINES
- 7.5.1 DIPHTHERIA
- 7.5.2 TETANUS
7.6 DNA VACCINES
7.7 VIRAL VECTOR VACCINES

8 EUROPE TRAVEL VACCINE MARKET, BY CATEGORY

8.1 OVERVIEW
8.2 RECOMMENDED VACCINE
- 8.2.1 TYPHOID FEVER VACCINES
- 8.2.2 HEPATITIS A
- 8.2.3 CHOLERA
- 8.2.4 RABIES
- 8.2.5 TICK-BORNE ENCEPHALITIS
- 8.2.6 JAPANESE ENCEPHALITIS
- 8.2.7 MALARIA
- 8.2.8 OTHERS
8.3 ROUTINE VACCINE
- 8.3.1 HEPATITIS B
- 8.3.2 INFLUENZA VACCINES
- 8.3.3 PNEUMOCOCCAL
- 8.3.4 DIPHTHERIA
- 8.3.5 TETANUS
- 8.3.6 MEASLES
- 8.3.7 MUMPS
- 8.3.8 RUBELLA
- 8.3.9 PERTUSSIS
- 8.3.10 OTHERS
8.4 REQUIRED VACCINE
- 8.4.1 YELLOW FEVER
- 8.4.2 MENINGOCOCCAL
- 8.4.3 POLIO VACCINES

9 EUROPE TRAVEL VACCINE MARKET, BY DISEASE

9.1 OVERVIEW
9.2 TYPHOID
9.3 HEPATITIS
- 9.3.1 HEPATITIS A
- 9.3.2 HEPATITIS B
9.4 CHOLERA
9.5 VARICELLA
9.6 INFLUENZA
9.7 JAPANESE ENCEPHALITIS
9.8 MENINGOCOCCAL MENINGITIS
9.9 YELLOW FEVER
9.10 RABIES
9.11 DPT
9.12 MEASLES AND MUMPS
9.13 TICK-BORNE ENCEPHALITIS
9.14 MALARIA
9.15 COVID-19
9.16 POLIO
9.17 OTHERS

10 EUROPE TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION

10.1 OVERVIEW
10.2 INJECTABLE
- 10.2.1 INTRAMUSCULAR
- 10.2.2 SUBCUTANEOUS
- 10.2.3 OTHERS
10.3 ORAL

11 EUROPE TRAVEL VACCINE MARKET, BY GENDER

11.1 OVERVIEW
11.2 MALE
11.3 FEMALE

12 EUROPE TRAVEL VACCINE MARKET, BY PATIENT TYPE

12.1 OVERVIEW
12.2 ADULT
12.3 PEDIATRIC
12.4 GERIATRIC

13 EUROPE TRAVEL VACCINE MARKET, BY AGE GROUP

13.1 OVERVIEW
13.2 20-50 YEARS
13.3 LESS THAN 20 YEARS
13.4 ABOVE 50 YEARS

14 EUROPE TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW
14.2 B2B
14.3 B2C

15 EUROPE TRAVEL VACCINE MARKET, BY REGION

15.1 EUROPE
- 15.1.1 GERMANY
- 15.1.2 U.K.
- 15.1.3 FRANCE
- 15.1.4 RUSSIA
- 15.1.5 ITALY
- 15.1.6 SPAIN
- 15.1.7 POLAND
- 15.1.8 NETHERLANDS
- 15.1.9 SWITZERLAND
- 15.1.10 HUNGARY
- 15.1.11 AUSTRIA
- 15.1.12 IRELAND
- 15.1.13 NORWAY
- 15.1.14 LITHUANIA
- 15.1.15 REST OF EUROPE

16 EUROPE TRAVEL VACCINE MARKET: COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: EUROPE

17 SWOT ANALYSIS

18 COMPANY PROFILE

18.1 PFIZER INC.
- 18.1.1 COMPANY SNAPSHOT
- 18.1.2 REVENUE ANALYSIS
- 18.1.3 COMPANY SHARE ANALYSIS
- 18.1.4 PRODUCT PORTFOLIO
- 18.1.5 RECENT DEVELOPMENT
18.2 SANOFI
- 18.2.1 COMPANY SNAPSHOT
- 18.2.2 REVENUE ANALYSIS
- 18.2.3 COMPANY SHARE ANALYSIS
- 18.2.4 PRODUCT PORTFOLIO
- 18.2.5 RECENT DEVELOPMENT
18.3 JOHNSON & JOHNSON SERVICES INC.
- 18.3.1 COMPANY SNAPSHOT
- 18.3.2 REVENUE ANALYSIS
- 18.3.3 COMPANY SHARE ANALYSIS
- 18.3.4 PRODUCT PORTFOLIO
- 18.3.5 RECENT DEVELOPMENTS
18.4 GSK PLC.
- 18.4.1 COMPANY SNAPSHOT
- 18.4.2 REVENUE ANALYSIS
- 18.4.3 COMPANY SHARE ANALYSIS
- 18.4.4 PRODUCT PORTFOLIO
- 18.4.5 RECENT DEVELOPMENT
18.5 MERCK & CO., INC.
- 18.5.1 COMPANY SNAPSHOT
- 18.5.2 REVENUE ANALYSIS
- 18.5.3 COMPANY SHARE ANALYSIS
- 18.5.4 PRODUCT PORTFOLIO
- 18.5.5 RECENT DEVELOPMENT
18.6 ABBOTT
- 18.6.1 COMPANY SNAPSHOT
- 18.6.2 REVENUE ANALYSIS
- 18.6.3 PRODUCT PORTFOLIO
- 18.6.4 RECENT DEVELOPMENT
18.7 ASTRAZENECA
- 18.7.1 COMPANY SNAPSHOT
- 18.7.2 REVENUE ANALYSIS
- 18.7.3 PRODUCT PORTFOLIO
- 18.7.4 RECENT DEVELOPMENT
18.8 BAVARIAN NORDIC
- 18.8.1 COMPANY SNAPSHOT
- 18.8.2 REVENUE ANALYSIS
- 18.8.3 PRODUCT PORTFOLIO
- 18.8.4 RECENT DEVELOPMENT
18.9 CSL
- 18.9.1 COMPANY SNAPSHOT
- 18.9.2 REVENUE ANALYSIS
- 18.9.3 PRODUCT PORTFOLIO
- 18.9.4 RECENT DEVELOPMENT
18.10 DYNAVAX TECHNOLOGIES.
- 18.10.1 COMPANY SNAPSHOT
- 18.10.2 REVENUE ANALYSIS
- 18.10.3 PRODUCT PORTFOLIO
- 18.10.4 RECENT DEVELOPMENTS
18.11 VALNEVA SE
- 18.11.1 COMPANY SNAPSHOT
- 18.11.2 REVENUE ANALYSIS
- 18.11.3 PRODUCT PORTFOLIO
- 18.11.4 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

LIST OF TABLES

TABLE 1 PIPELINE ANALYSIS OF TRAVEL VACCINES MARKET
TABLE 2 VACCINES RECOMMENDATION FOR INTERNATIONAL TRAVELERS
TABLE 3 EUROPE TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 4 EUROPE COMBINATION VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 5 EUROPE MONO VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 6 EUROPE TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 7 EUROPE INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 8 EUROPE INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 9 EUROPE SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 10 EUROPE SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 11 EUROPE LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 12 EUROPE LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 13 EUROPE TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 14 EUROPE TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 15 EUROPE DNA VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 16 EUROPE VIRAL VECTOR VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 17 EUROPE TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 18 EUROPE RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 19 EUROPE RECOMMENDED VACCINES IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 20 EUROPE ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 21 EUROPE ROUTINE VACCINES IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 22 EUROPE REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 23 EUROPE REQUIRED VACCINES IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 24 EUROPE TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 25 EUROPE TYPHOID IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 26 EUROPE HEPATITIS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 27 EUROPE HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 28 EUROPE CHOLERA IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 29 EUROPE VARICELLA IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 30 EUROPE INFLUENZA IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 31 EUROPE JAPANESE ENCEPHALITIS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 32 EUROPE MENINGOCOCCAL MENINGITIS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 33 EUROPE YELLOW FEVER IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 34 EUROPE RABIES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 35 EUROPE DPT IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 36 EUROPE MEASLES AND MUMPS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 37 EUROPE TICK-BORNE ENCEPHALITIS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 38 EUROPE MALARIA IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 39 EUROPE COVID-19 IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 40 EUROPE POLIO IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 41 EUROPE OTHERS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 42 EUROPE TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 43 EUROPE INJECTABLE IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 44 EUROPE INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 45 EUROPE ORAL IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 46 EUROPE TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 47 EUROPE MALE IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 48 EUROPE FEMALE IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 49 EUROPE TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 50 EUROPE ADULT IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 51 EUROPE PEDIATRIC IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 52 EUROPE GERIATRIC IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 53 EUROPE TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 54 EUROPE 20-50 YEARS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 55 EUROPE LESS THAN 20 YEARS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 56 EUROPE ABOVE 50 YEARS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 57 EUROPE TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 58 EUROPE B2B IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 59 EUROPE B2C IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 60 EUROPE TRAVEL VACCINE MARKET, BY COUNTRY, 2022-2032 (USD THOUSAND)
TABLE 61 EUROPE TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 62 EUROPE TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 63 EUROPE INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 64 EUROPE SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 65 EUROPE LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 66 EUROPE TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 67 EUROPE TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 68 EUROPE RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 69 EUROPE ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 70 EUROPE REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 71 EUROPE TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 72 EUROPE HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 73 EUROPE TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 74 EUROPE INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 75 EUROPE TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 76 EUROPE TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 77 EUROPE TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 78 EUROPE TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 79 GERMANY TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 80 GERMANY TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 81 GERMANY INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 82 GERMANY SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 83 GERMANY LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 84 GERMANY TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 85 GERMANY TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 86 GERMANY RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 87 GERMANY ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 88 GERMANY REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 89 GERMANY TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 90 GERMANY HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 91 GERMANY TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 92 GERMANY INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 93 GERMANY TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 94 GERMANY TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 95 GERMANY TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 96 GERMANY TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 97 U.K. TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 98 U.K. TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 99 U.K. INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 100 U.K. SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 101 U.K. LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 102 U.K. TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 103 U.K. TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 104 U.K. RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 105 U.K. ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 106 U.K. REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 107 U.K. TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 108 U.K. HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 109 U.K. TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 110 U.K. INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 111 U.K. TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 112 U.K. TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 113 U.K. TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 114 U.K. TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 115 FRANCE TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 116 FRANCE TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 117 FRANCE INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 118 FRANCE SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 119 FRANCE LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 120 FRANCE TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 121 FRANCE TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 122 FRANCE RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 123 FRANCE ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 124 FRANCE REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 125 FRANCE TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 126 FRANCE HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 127 FRANCE TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 128 FRANCE INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 129 FRANCE TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 130 FRANCE TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 131 FRANCE TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 132 FRANCE TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 133 RUSSIA TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 134 RUSSIA TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 135 RUSSIA INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 136 RUSSIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 137 RUSSIA LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 138 RUSSIA TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 139 RUSSIA TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 140 RUSSIA RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 141 RUSSIA ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 142 RUSSIA REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 143 RUSSIA TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 144 RUSSIA HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 145 RUSSIA TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 146 RUSSIA INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 147 RUSSIA TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 148 RUSSIA TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 149 RUSSIA TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 150 RUSSIA TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 151 ITALY TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 152 ITALY TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 153 ITALY INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 154 ITALY SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 155 ITALY LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 156 ITALY TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 157 ITALY TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 158 ITALY RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 159 ITALY ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 160 ITALY REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 161 ITALY TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 162 ITALY HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 163 ITALY TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 164 ITALY INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 165 ITALY TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 166 ITALY TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 167 ITALY TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 168 ITALY TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 169 SPAIN TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 170 SPAIN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 171 SPAIN INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 172 SPAIN SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 173 SPAIN LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 174 SPAIN TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 175 SPAIN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 176 SPAIN RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 177 SPAIN ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 178 SPAIN REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 179 SPAIN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 180 SPAIN HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 181 SPAIN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 182 SPAIN INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 183 SPAIN TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 184 SPAIN TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 185 SPAIN TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 186 SPAIN TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 187 POLAND TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 188 POLAND TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 189 POLAND INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 190 POLAND SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 191 POLAND LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 192 POLAND TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 193 POLAND TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 194 POLAND RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 195 POLAND ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 196 POLAND REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 197 POLAND TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 198 POLAND HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 199 POLAND TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 200 POLAND INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 201 POLAND TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 202 POLAND TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 203 POLAND TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 204 POLAND TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 205 NETHERLANDS TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 206 NETHERLANDS TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 207 NETHERLANDS INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 208 NETHERLANDS SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 209 NETHERLANDS LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 210 NETHERLANDS TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 211 NETHERLANDS TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 212 NETHERLANDS RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 213 NETHERLANDS ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 214 NETHERLANDS REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 215 NETHERLANDS TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 216 NETHERLANDS HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 217 NETHERLANDS TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 218 NETHERLANDS INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 219 NETHERLANDS TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 220 NETHERLANDS TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 221 NETHERLANDS TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 222 NETHERLANDS TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 223 SWITZERLAND TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 224 SWITZERLAND TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 225 SWITZERLAND INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 226 SWITZERLAND SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 227 SWITZERLAND LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 228 SWITZERLAND TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 229 SWITZERLAND TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 230 SWITZERLAND RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 231 SWITZERLAND ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 232 SWITZERLAND REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 233 SWITZERLAND TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 234 SWITZERLAND HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 235 SWITZERLAND TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 236 SWITZERLAND INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 237 SWITZERLAND TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 238 SWITZERLAND TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 239 SWITZERLAND TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 240 SWITZERLAND TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 241 HUNGARY TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 242 HUNGARY TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 243 HUNGARY INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 244 HUNGARY SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 245 HUNGARY LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 246 HUNGARY TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 247 HUNGARY TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 248 HUNGARY RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 249 HUNGARY ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 250 HUNGARY REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)

TABLE 251 HUNGARY TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 252 HUNGARY HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 253 HUNGARY TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 254 HUNGARY INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 255 HUNGARY TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 256 HUNGARY TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 257 HUNGARY TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 258 HUNGARY TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 259 AUSTRIA TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 260 AUSTRIA TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 261 AUSTRIA INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 262 AUSTRIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 263 AUSTRIA LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 264 AUSTRIA TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 265 AUSTRIA TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 266 AUSTRIA RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 267 AUSTRIA ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 268 AUSTRIA REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 269 AUSTRIA TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 270 AUSTRIA HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 271 AUSTRIA TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 272 AUSTRIA INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 273 AUSTRIA TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 274 AUSTRIA TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 275 AUSTRIA TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 276 AUSTRIA TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 277 IRELAND TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 278 IRELAND TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 279 IRELAND INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 280 IRELAND SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 281 IRELAND LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 282 IRELAND TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 283 IRELAND TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 284 IRELAND RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 285 IRELAND ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 286 IRELAND REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 287 IRELAND TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 288 IRELAND HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 289 IRELAND TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 290 IRELAND INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 291 IRELAND TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 292 IRELAND TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 293 IRELAND TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 294 IRELAND TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 295 NORWAY TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 296 NORWAY TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 297 NORWAY INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 298 NORWAY SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 299 NORWAY LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 300 NORWAY TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 301 NORWAY TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 302 NORWAY RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 303 NORWAY ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 304 NORWAY REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 305 NORWAY TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 306 NORWAY HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 307 NORWAY TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 308 NORWAY INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 309 NORWAY TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 310 NORWAY TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 311 NORWAY TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 312 NORWAY TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 313 LITHUANIA TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 314 LITHUANIA TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 315 LITHUANIA INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 316 LITHUANIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 317 LITHUANIA LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 318 LITHUANIA TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 319 LITHUANIA TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 320 LITHUANIA RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 321 LITHUANIA ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 322 LITHUANIA REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 323 LITHUANIA TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 324 LITHUANIA HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 325 LITHUANIA TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 326 LITHUANIA INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 327 LITHUANIA TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 328 LITHUANIA TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 329 LITHUANIA TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 330 LITHUANIA TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 331 REST OF EUROPE TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)

LIST OF FIGURES

FIGURE 1 EUROPE TRAVEL VACCINES MARKET: SEGMENTATION
FIGURE 2 EUROPE TRAVEL VACCINES MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE TRAVEL VACCINES MARKET: DROC ANALYSIS
FIGURE 4 EUROPE TRAVEL VACCINES MARKET : EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE TRAVEL VACCINES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE TRAVEL VACCINES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE TRAVEL VACCINES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE TRAVEL VACCINES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 EUROPE TRAVEL VACCINES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE TRAVEL VACCINES MARKET: SEGMENTATION
FIGURE 11 RISING AWARENESS ABOUT THE IMPORTANCE OF VACCINATION AMONG TRAVELERS ARE EXPECTED TO DRIVE THE EUROPE TRAVEL VACCINES MARKET IN THE FORECAST PERIOD OF 2024 TO 2032
FIGURE 12 COMBINATION VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE TRAVEL VACCINES MARKET IN 2021 & 2032
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE TRAVEL VACCINE MARKET
FIGURE 14 EUROPE TRAVEL VACCINE MARKET: BY COMPOSITION, 2023
FIGURE 15 EUROPE TRAVEL VACCINE MARKET: BY COMPOSITION, 2024-2032 (USD THOUSAND)
FIGURE 16 EUROPE TRAVEL VACCINE MARKET: BY COMPOSITION , CAGR (2024-2032)
FIGURE 17 EUROPE TRAVEL VACCINE MARKET: BY COMPOSITION, LIFELINE CURVE
FIGURE 18 EUROPE TRAVEL VACCINE MARKET: BY TYPE, 2023
FIGURE 19 EUROPE TRAVEL VACCINE MARKET: BY TYPE, 2024-2032 (USD THOUSAND)
FIGURE 20 EUROPE TRAVEL VACCINE MARKET: BY TYPE, CAGR (2024-2032)
FIGURE 21 EUROPE TRAVEL VACCINE MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 EUROPE TRAVEL VACCINE MARKET: BY CATEGORY, 2023
FIGURE 23 EUROPE TRAVEL VACCINE MARKET: BY CATEGORY, 2024-2032 (USD THOUSAND)
FIGURE 24 EUROPE TRAVEL VACCINE MARKET: BY CATEGORY, CAGR (2024-2032)
FIGURE 25 EUROPE TRAVEL VACCINE MARKET: BY CATEGORY, LIFELINE CURVE
FIGURE 26 EUROPE TRAVEL VACCINE MARKET: BY DISEASE, 2023
FIGURE 27 EUROPE TRAVEL VACCINE MARKET: BY DISEASE, 2024-2032 (USD THOUSAND)
FIGURE 28 EUROPE TRAVEL VACCINE MARKET: BY DISEASE, CAGR (2024-2032)
FIGURE 29 EUROPE TRAVEL VACCINE MARKET: BY DISEASE, LIFELINE CURVE
FIGURE 30 EUROPE TRAVEL VACCINE MARKET: BY ROUTE OF ADMINISTRATION, 2023
FIGURE 31 EUROPE TRAVEL VACCINE MARKET: BY ROUTE OF ADMINISTRATION, 2024-2032 (USD THOUSAND)
FIGURE 32 EUROPE TRAVEL VACCINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2024-2032)
FIGURE 33 EUROPE TRAVEL VACCINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 34 EUROPE TRAVEL VACCINE MARKET: BY GENDER, 2023
FIGURE 35 EUROPE TRAVEL VACCINE MARKET: BY GENDER, 2024-2032 (USD THOUSAND)
FIGURE 36 EUROPE TRAVEL VACCINE MARKET: BY GENDER, CAGR (2024-2032)
FIGURE 37 EUROPE TRAVEL VACCINE MARKET: BY GENDER, LIFELINE CURVE
FIGURE 38 EUROPE TRAVEL VACCINE MARKET: BY PATIENT TYPE, 2023
FIGURE 39 EUROPE TRAVEL VACCINE MARKET: BY PATIENT TYPE, 2024-2032 (USD THOUSAND)
FIGURE 40 EUROPE TRAVEL VACCINE MARKET: BY PATIENT TYPE, CAGR (2024-2032)
FIGURE 41 EUROPE TRAVEL VACCINE MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 42 EUROPE TRAVEL VACCINE MARKET: BY AGE GROUP, 2023
FIGURE 43 EUROPE TRAVEL VACCINE MARKET: BY AGE GROUP, 2024-2032 (USD THOUSAND)
FIGURE 44 EUROPE TRAVEL VACCINE MARKET: BY AGE GROUP, CAGR (2024-2032)
FIGURE 45 EUROPE TRAVEL VACCINE MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 46 EUROPE TRAVEL VACCINE MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 47 EUROPE TRAVEL VACCINE MARKET: BY DISTRIBUTION CHANNEL, 2024-2032 (USD THOUSAND)
FIGURE 48 EUROPE TRAVEL VACCINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2032)
FIGURE 49 EUROPE TRAVEL VACCINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 50 EUROPE TRAVEL VACCINE MARKET: SNAPSHOT (2023)
FIGURE 51 EUROPE TRAVEL VACCINE MARKET: COMPANY SHARE 2023 (%)